1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Fecal Incontinence Global Clinical Trials Review, H1, 2015

Fecal Incontinence Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Fecal Incontinence Global Clinical Trials Review, H1, 2015" provides data on the Fecal Incontinence clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fecal Incontinence. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Fecal Incontinence. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Fecal Incontinence Global Clinical Trials Review, H1, 2015
Introduction 6
Fecal Incontinence 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Fecal Incontinence to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Unaccomplished Trials of Fecal Incontinence 22
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Fecal Incontinence Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Norgine B.V. 29
Clinical Trial Overview of Norgine B.V. 29
RDD Pharma Ltd. 30
Clinical Trial Overview of RDD Pharma Ltd. 30
Innovacell Biotechnologie AG 31
Clinical Trial Overview of Innovacell Biotechnologie AG 31
Salix Pharmaceuticals Ltd. 32
Clinical Trial Overview of Salix Pharmaceuticals Ltd. 32
S.L.A. Pharma AG 33
Clinical Trial Overview of S.L.A. Pharma AG 33
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
GlaxoSmithKline plc 35
Clinical Trial Overview of GlaxoSmithKline plc 35
Cook Medical Incorporated 36
Clinical Trial Overview of Cook Medical Incorporated 36
Anterogen Co., Ltd. 37
Clinical Trial Overview of Anterogen Co., Ltd. 37
Clinical Trial Overview of Top Institutes / Government 38
Centre Hospitalier Universitaire de Nimes 38
Clinical Trial Overview of Centre Hospitalier Universitaire de Nimes 38
University of Wisconsin Madison 39
Clinical Trial Overview of University of Wisconsin Madison 39
U.S. Department of Veterans Affairs 40
Clinical Trial Overview of U.S. Department of Veterans Affairs 40
The National Institute of Diabetes and Digestive and Kidney Diseases 41
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 41
North West London Hospitals NHS Trust 42
Clinical Trial Overview of North West London Hospitals NHS Trust 42
Cantonal Hospital 43
Clinical Trial Overview of Cantonal Hospital 43
Aarhus University 44
Clinical Trial Overview of Aarhus University 44
James Cook University 45
Clinical Trial Overview of James Cook University 45
Herlev Hospital 46
Clinical Trial Overview of Herlev Hospital 46
Rouen University Hospital 47
Clinical Trial Overview of Rouen University Hospital 47
Five Key Clinical Profiles 48
Appendix 63
Abbreviations 63
Definitions 63
Research Methodology 64
Secondary Research 64
About GlobalData 65
Contact Us 65
Disclaimer 65
Source 65

List of Tables

Fecal Incontinence Therapeutics, Global, Clinical Trials by Region, 2015* 7
Fecal Incontinence Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Fecal Incontinence Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Fecal Incontinence Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Fecal Incontinence Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Fecal Incontinence Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Fecal Incontinence Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Fecal Incontinence Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Fecal Incontinence to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Fecal Incontinence Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Fecal Incontinence Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Fecal Incontinence Therapeutics, Global, Clinical Trials by Phase, 2015* 18
Fecal Incontinence Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 19
Fecal Incontinence Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20
Fecal Incontinence Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21
Fecal Incontinence Therapeutics, Global, Suspended Clinical Trials, 2015* 22
Fecal Incontinence Therapeutics, Global, Withdrawn Clinical Trials, 2015* 22
Fecal Incontinence Therapeutics, Global, Terminated Clinical Trials, 2015* 23
Fecal Incontinence Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Fecal Incontinence Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 25
Fecal Incontinence Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Fecal Incontinence Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
Fecal Incontinence Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28
Fecal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Norgine B.V., 2015* 29
Fecal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by RDD Pharma Ltd., 2015* 30
Fecal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Innovacell Biotechnologie AG, 2015* 31
Fecal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Salix Pharmaceuticals Ltd., 2015* 32
Fecal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by S.L.A. Pharma AG, 2015* 33
Fecal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 34
Fecal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 35
Fecal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Cook Medical Incorporated, 2015* 36
Fecal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Anterogen Co., Ltd., 2015* 37
Fecal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Nimes, 2015* 38
Fecal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2015* 39
Fecal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2015* 40
Fecal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015* 41
Fecal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by North West London Hospitals NHS Trust, 2015* 42
Fecal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Cantonal Hospital, 2015* 43
Fecal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2015* 44
Fecal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by James Cook University, 2015* 45
Fecal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Herlev Hospital, 2015* 46
Fecal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Rouen University Hospital, 2015* 47

List of Figures

Fecal Incontinence Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Fecal Incontinence Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Fecal Incontinence Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Fecal Incontinence Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Fecal Incontinence Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Fecal Incontinence Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Fecal Incontinence Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Fecal Incontinence to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Fecal Incontinence Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Fecal Incontinence Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Fecal Incontinence Therapeutics, Global, Clinical Trials by Phase (%), 2015* 18
Fecal Incontinence Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 19
Fecal Incontinence Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20
Fecal Incontinence Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21
Fecal Incontinence Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Fecal Incontinence Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 25
Fecal Incontinence Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Fecal Incontinence Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
Fecal Incontinence Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28
GlobalData Methodology 64

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.